SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition
Coronavirus disease 2019 (COVID-19) is an acute complex systemic disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).While SARS-CoV-2 is known to cause significant pulmonary disease, various extrapulmonary manifestations of COVID-19 have also been reported. Growing ev...
Saved in:
Main Authors: | Alena Strýčková, Jakub Benko, Martin Jozef Péč, Monika Péčová, Jana Žolková, Monika Brunclíková, Tomáš Bolek, Ján Staško, Matej Samoš, Marián Mokáň |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/7805900 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
by: Dana Prídavková, et al.
Published: (2019-01-01) -
The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
by: Matej Samoš, et al.
Published: (2016-01-01) -
Type 2 Diabetes and ADP Receptor Blocker Therapy
by: Matej Samoš, et al.
Published: (2016-01-01) -
Carboxypeptidase B1 in dialyzed chronic kidney disease patients
by: Matej Stančík, et al.
Published: (2025-02-01) -
Clinical Scenarios for Discordant Anti-Xa
by: Jesus Vera-Aguilera, et al.
Published: (2016-01-01)